Search

Roundtable Discussion: Marijuana Rescheduling, Cannabidiol (CBD) Product Pathways, and More While interest in cannabis and cannabis-derived products remains high, the near- and long-term future of federal regulation remains hazy. Hear directly from FDA as they discuss regulation and enforcement in...

In a conversational 30-minute forum over Zoom, Saul Ewing attorneys hosted a discussion on emerging industry developments and common issues that cannabis businesses face today. This month's program featured content covering current regulatory landscape and how it impacts your business. Interested in...